CareDx Completes $20 Million Public Offering

Craig-Hallum Capital Group, acting as the sole book-running manager, and H.C. Wainwright & Co., acting as co-manager, completed an upsized $20.0 million public offering of common stock for CareDx, Inc., a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients. The offering closed on October 10, 2017. Our firm represented the underwriters in the transaction.